Over the last decades, the number of pancreas transplants has increased all over the world.
Since the first pancreas transplant in 1966, patient and graft survival after simultaneous …

Pancreas transplantation (PTx) reestablishes an autoregulating source of endogenous
insulin responsive to normal feedback controls. In addition to achieving complete β-cell …

Objective: The REDISCOVER consensus conference aimed at developing and validating
guidelines on the perioperative care of patients with borderline-resectable (BR-) and locally …

Type 1 diabetes is a disease resulting from autoimmune destruction of the insulin-producing
beta cells in the pancreas. When type 1 diabetes develops into severe secondary …

Type 1 diabetes mellitus (T1DM) is one of the important causes of chronic kidney disease
(CKD) and end-stage renal failure (ESRF). Even with the best available treatment options …

Successful pancreas or islet transplantation is currently the only cure for type 1 diabetes
mellitus. Since the first pancreas transplant in 1966, there have been various refinements of …

Introduction Despite significant advancements in immunosuppressive regimens and surgical
techniques, the prevalence of adverse events related to immunosuppression remains a …

Solid organ transplantation represents the best (and in many cases only) treatment option
for patients with end‐stage organ failure. The effectiveness and functioning life of these …

Since the first pancreas transplant in 1966, over 67,000 pancreas transplants have been
performed worldwide and the number is growing. While the number of transplants in the US …

The Banff pancreas working schema for diagnosis and grading of rejection is widely used for
treatment guidance and risk stratification in centers that perform pancreas allograft biopsies …